Home
/
Orthofix Medical Inc.
/
Financials
/
Quarterly
Orthofix Medical Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Orthofix Medical Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$205.63M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$203.12M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$193.65M
May 6, 2025
Q3
2025
Sep 30, 2024
$196.61M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$198.62M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$188.61M
May 6, 2025
Q3
2024
Sep 30, 2023
$184.01M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$187.02M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$175.20M
May 7, 2024
Q3
2023
Sep 30, 2022
$114.00M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$118.07M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$106.42M
May 9, 2023
Q3
2022
Sep 30, 2021
$112.43M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$121.39M
Aug 5, 2022
Q1
2022
Mar 31, 2021
$105.59M
May 6, 2022
Q3
2021
Sep 30, 2020
$110.99M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$73.14M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$104.82M
Apr 30, 2021
Q3
2020
Sep 30, 2019
$113.50M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$115.85M
Aug 6, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$108.71M
Apr 30, 2018
Q3
2017
Sep 30, 2017
$105.25M
Oct 30, 2017
Q2
2017
Jun 30, 2017
$108.94M
Aug 7, 2017
Q1
2018
Mar 31, 2017
$102.74M
Apr 30, 2018
Q3
2017
Sep 30, 2016
$98.50M
Oct 30, 2017
Q2
2017
Jun 30, 2016
$104.08M
Aug 7, 2017
Q1
2017
Mar 31, 2016
$98.68M
May 4, 2017
Q3
2016
Sep 30, 2015
$101.15M
Oct 31, 2016
Q2
2016
Jun 30, 2015
$100.95M
Aug 1, 2016
Q1
2016
Mar 31, 2015
$89.76M
Apr 28, 2016
Q3
2015
Sep 30, 2014
$100.99M
Nov 3, 2015
Q2
2015
Jun 30, 2014
$100.99M
Aug 4, 2015
Q1
2015
Mar 31, 2014
$100.01M
May 18, 2015
Q3
2014
Sep 30, 2013
$91.81M
Mar 31, 2015
Q2
2014
Jun 30, 2013
$97.64M
Mar 31, 2015
Q1
2014
Mar 31, 2013
$102.28M
Mar 31, 2015
Q3
2013
Sep 30, 2012
$107.86M
Mar 25, 2014
Q2
2013
Jun 30, 2012
$113.42M
Mar 24, 2014
Q1
2013
Mar 31, 2012
$108.94M
Mar 24, 2014
Q3
2012
Sep 30, 2011
$117.31M
Nov 2, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.80M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($14.08M)
Aug 5, 2025
Q3
2025
Jun 30, 2025
($14.08M)
Nov 4, 2025
Q2
2025
Mar 31, 2025
($53.09M)
Aug 5, 2025
Q3
2025
Mar 31, 2025
($53.09M)
Nov 4, 2025
Q1
2025
Mar 31, 2025
($53.09M)
May 6, 2025
Q3
2025
Sep 30, 2024
($27.39M)
Nov 4, 2025
Q3
2025
Jun 30, 2024
($33.44M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($33.44M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($36.02M)
May 6, 2025
Q2
2025
Mar 31, 2024
($36.02M)
Aug 5, 2025
Q3
2025
Mar 31, 2024
($36.02M)
Nov 4, 2025
Q3
2024
Sep 30, 2023
($28.86M)
Nov 7, 2024
Q3
2024
Jun 30, 2023
($39.43M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($39.43M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($60.94M)
May 7, 2024
Q2
2024
Mar 31, 2023
($60.94M)
Aug 6, 2024
Q3
2024
Mar 31, 2023
($60.94M)
Nov 7, 2024
Q3
2023
Sep 30, 2022
($10.72M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
$2.49M
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.05M)
Nov 4, 2025
Q2
2025
Jun 30, 2025
($16.00M)
Aug 5, 2025
Q1
2025
Mar 31, 2025
($48.87M)
May 6, 2025
Q3
2025
Sep 30, 2024
($18.90M)
Nov 4, 2025
Q2
2025
Jun 30, 2024
($24.91M)
Aug 5, 2025
Q1
2025
Mar 31, 2024
($29.34M)
May 6, 2025
Q3
2024
Sep 30, 2023
($24.45M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($36.63M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($59.71M)
May 7, 2024
Q3
2023
Sep 30, 2022
($5.79M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
$6.64M
Aug 8, 2023
Q1
2023
Mar 31, 2022
($3.08M)
May 9, 2023
Q3
2022
Sep 30, 2021
($313.0K)
Nov 3, 2022
Q2
2022
Jun 30, 2021
$4.27M
Aug 5, 2022
Q1
2022
Mar 31, 2021
($2.92M)
May 6, 2022
Q3
2021
Sep 30, 2020
$4.18M
Nov 5, 2021
Q2
2021
Jun 30, 2020
($21.00M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
$6.85M
Apr 30, 2021
Q3
2020
Sep 30, 2019
($18.88M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
$451.0K
Aug 6, 2020